MedTrace Logo

COVID-19 Testing Sample Acquisition Throughput and Efficiency

NCT04532411 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28948

Last updated 2023-10-23

No results posted yet for this study

Summary

This QI project seeks to evaluate the relative test sample acquisition throughput, personal protective equipment utilization, and relative operational costs of provider-administered COVID-19 (SARS-CoV-2) nasal samples with and with the use of HEPA-filtered, positive pressure isolation booths.

Conditions

  • SARS-CoV Infection
  • Respiratory Viral Infection
  • Personal Protective Equipment
  • Covid19

Interventions

OTHER

Personal Protective Testing Booth

Health personnel who utilize the Hexapod will remain in the booth and utilize durable gloves attached to ports through a plexiglass wall in order to administer a nasal swab for SARS-CoV-2 (COVID-19) testing. Patient escorts and housekeeping/sanitation staff perform additional tasks outside of the booth such as escorting the patient to the correct testing bay and dropping off testing vials and printed information, collect samples and deposit in the appropriate location after testing is complete, and sanitizing the patient bay before a subsequent patient is tested there.

Sponsors & Collaborators

  • Massachusetts General Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2020-09-30
Completion
2020-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04532411 on ClinicalTrials.gov